Yaotang Biology

company

About

Yaotang Bio is a biotechnology company focusing on combining LNP delivery and gene editing technology.

Details

Last Funding Type
Angel
Industries
Biopharma,Biotechnology
Founded date
Jul 1, 2021
Operating Status
Active

Yaotang (Shanghai) Biotechnology is a high-tech biotechnology company focusing on developing a new generation of mRNA drugs and gene editing drugs by combining mRNA in vivo delivery technology and gene editing technology. Through the continuous development and optimization of CRISPR, base editing and other new-generation gene editing tools, and innovative improvements to the next-generation mRNA production platform and lipid nanocarrier assembly process, Yaotang Bio is committed to developing treatments for genetic diseases and cardiovascular disease.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
Yaotang Biology has raised a total of — in funding over 2 rounds. Their latest funding was raised on Feb 25, 2022 from a Angel round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Feb 25, 2022 Angel 1 Xianfeng Qiyun Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Yaotang Biology is funded by 1 investors. Xianfeng Qiyun are the most recent investors.
Investor Name Lead Investor Funding Round
Xianfeng Qiyun Yes Angel